Annual CFO
-$108.56 M
-$64.68 M-147.41%
December 31, 2024
Summary
- As of March 14, 2025, ABCL annual cash flow from operations is -$108.56 million, with the most recent change of -$64.68 million (-147.41%) on December 31, 2024.
- During the last 3 years, ABCL annual CFO has fallen by -$353.14 million (-144.38%).
- ABCL annual CFO is now -139.14% below its all-time high of $277.36 million, reached on December 31, 2022.
Performance
ABCL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$8.00 M
+$20.88 M+72.30%
December 31, 2024
Summary
- As of March 14, 2025, ABCL quarterly cash flow from operations is -$8.00 million, with the most recent change of +$20.88 million (+72.30%) on December 31, 2024.
- Over the past year, ABCL quarterly CFO has increased by +$20.88 million (+72.30%).
- ABCL quarterly CFO is now -102.93% below its all-time high of $273.01 million, reached on June 30, 2022.
Performance
ABCL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$108.56 M
+$11.61 M+9.66%
December 31, 2024
Summary
- As of March 14, 2025, ABCL TTM cash flow from operations is -$108.56 million, with the most recent change of +$11.61 million (+9.66%) on December 31, 2024.
- Over the past year, ABCL TTM CFO has increased by +$11.61 million (+9.66%).
- ABCL TTM CFO is now -130.96% below its all-time high of $350.59 million, reached on June 30, 2022.
Performance
ABCL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ABCL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -147.4% | +72.3% | +9.7% |
| 3 y3 years | -144.4% | +72.3% | +9.7% |
| 5 y5 years | -4129.6% | +72.3% | +9.7% |
ABCL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -139.1% | at low | -102.9% | +93.7% | -131.0% | +9.7% |
| 5 y | 5-year | -139.1% | at low | -102.9% | +93.7% | -131.0% | +9.7% |
| alltime | all time | -139.1% | at low | -102.9% | +93.7% | -131.0% | +9.7% |
AbCellera Biologics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$108.56 M(+147.4%) | -$8.00 M(-72.3%) | -$108.56 M(-9.7%) |
| Sep 2024 | - | -$28.88 M(-3.6%) | -$120.17 M(+31.5%) |
| Jun 2024 | - | -$29.97 M(-28.2%) | -$91.39 M(+120.1%) |
| Mar 2024 | - | -$41.71 M(+112.7%) | -$41.52 M(-5.4%) |
| Dec 2023 | -$43.88 M(-115.8%) | -$19.61 M(>+9900.0%) | -$43.88 M(-760.2%) |
| Sep 2023 | - | -$106.00 K(-100.5%) | $6.65 M(-105.5%) |
| Jun 2023 | - | $19.90 M(-145.2%) | -$120.03 M(-190.2%) |
| Mar 2023 | - | -$44.06 M(-242.5%) | $133.08 M(-52.0%) |
| Dec 2022 | $277.36 M | $30.91 M(-124.4%) | $277.36 M(+20.7%) |
| Sep 2022 | - | -$126.79 M(-146.4%) | $229.74 M(-34.5%) |
| Jun 2022 | - | $273.01 M(+172.4%) | $350.59 M(+49.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $100.22 M(-699.7%) | $235.26 M(-3.8%) |
| Dec 2021 | $244.58 M(+977.9%) | -$16.71 M(+181.7%) | $244.58 M(-6.9%) |
| Sep 2021 | - | -$5.93 M(-103.8%) | $262.57 M(-0.8%) |
| Jun 2021 | - | $157.68 M(+43.9%) | $264.70 M(+99.0%) |
| Mar 2021 | - | $109.55 M(+8471.6%) | $133.00 M(+486.2%) |
| Dec 2020 | $22.69 M(+742.2%) | $1.28 M(-133.6%) | $22.69 M(+6.0%) |
| Sep 2020 | - | -$3.80 M(-114.6%) | $21.41 M(-15.1%) |
| Jun 2020 | - | $25.98 M(-3500.1%) | $25.21 M(-3400.1%) |
| Mar 2020 | - | -$764.00 K | -$764.00 K |
| Dec 2019 | $2.69 M(-24.4%) | - | - |
| Dec 2018 | $3.56 M | - | - |
FAQ
- What is AbCellera Biologics annual cash flow from operations?
- What is the all time high annual CFO for AbCellera Biologics?
- What is AbCellera Biologics annual CFO year-on-year change?
- What is AbCellera Biologics quarterly cash flow from operations?
- What is the all time high quarterly CFO for AbCellera Biologics?
- What is AbCellera Biologics quarterly CFO year-on-year change?
- What is AbCellera Biologics TTM cash flow from operations?
- What is the all time high TTM CFO for AbCellera Biologics?
- What is AbCellera Biologics TTM CFO year-on-year change?
What is AbCellera Biologics annual cash flow from operations?
The current annual CFO of ABCL is -$108.56 M
What is the all time high annual CFO for AbCellera Biologics?
AbCellera Biologics all-time high annual cash flow from operations is $277.36 M
What is AbCellera Biologics annual CFO year-on-year change?
Over the past year, ABCL annual cash flow from operations has changed by -$64.68 M (-147.41%)
What is AbCellera Biologics quarterly cash flow from operations?
The current quarterly CFO of ABCL is -$8.00 M
What is the all time high quarterly CFO for AbCellera Biologics?
AbCellera Biologics all-time high quarterly cash flow from operations is $273.01 M
What is AbCellera Biologics quarterly CFO year-on-year change?
Over the past year, ABCL quarterly cash flow from operations has changed by +$20.88 M (+72.30%)
What is AbCellera Biologics TTM cash flow from operations?
The current TTM CFO of ABCL is -$108.56 M
What is the all time high TTM CFO for AbCellera Biologics?
AbCellera Biologics all-time high TTM cash flow from operations is $350.59 M
What is AbCellera Biologics TTM CFO year-on-year change?
Over the past year, ABCL TTM cash flow from operations has changed by +$11.61 M (+9.66%)